MRKR
Marker TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MRKR fundamentals
Marker Therapeutics (MRKR) released its earnings on Nov 13, 2025: revenue was 1.23M (YoY -35.98%), beat estimates; EPS was -0.12 (YoY +53.85%), beat estimates.
Revenue / YoY
1.23M
-35.98%
EPS / YoY
-0.12
+53.85%
Report date
Nov 13, 2025
EPS
Revenue
Revenue & Expenses
MRKR has released its 2025 Q3 earnings report, with revenue of 1.23M, reflecting a YoY change of -35.99%, and net profit of -2.00M, showing a YoY change of 13.41%. The Sankey diagram below clearly presents MRKR's revenue sources and cost distribution.
Key Indicators
Marker Therapeutics (MRKR) key financial stats and ratios, covering profitability, financial health, and leverage.
Marker Therapeutics (MRKR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Marker Therapeutics (MRKR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Marker Therapeutics (MRKR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Marker Therapeutics (MRKR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Marker Therapeutics (MRKR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Marker Therapeutics's revenue and profit?What is Marker Therapeutics's latest dividend and current dividend yield?What is Marker Therapeutics's gross profit margin?Did Marker Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Marker Therapeutics year over year?What does Marker Therapeutics do and what are its main business segments?What guidance did Marker Therapeutics's management provide for the next earnings period?What were the key takeaways from Marker Therapeutics's earnings call?
